APA (7th ed.) Citation

Baccelli, I., Stenzinger, A., Wallwiener, M., Sinn, P., Schneeweiss, A., & Weichert, W. (2014). Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients. OncoTarget, 5(18), .

Chicago Style (17th ed.) Citation

Baccelli, Irène, Albrecht Stenzinger, Markus Wallwiener, Peter Sinn, Andreas Schneeweiss, and Wilko Weichert. "Co-expression of MET and CD47 Is a Novel Prognosticator for Survival of Luminal-type Breast Cancer Patients." OncoTarget 5, no. 18 (2014).

MLA (9th ed.) Citation

Baccelli, Irène, et al. "Co-expression of MET and CD47 Is a Novel Prognosticator for Survival of Luminal-type Breast Cancer Patients." OncoTarget, vol. 5, no. 18, 2014.